Navigation Links
Pistachio Growers and Processors Announce New Web Site to Inform Consumers, Retailers of Pistachio Brands Not Containing Pistachios From Setton Pistachio of Terra Bella, Inc.
Date:4/6/2009

Pistachiorecall.org lists brands that do not contain pistachios from Setton

FRESNO, Calif., April 6 /PRNewswire/ -- Pistachio growers and processors today announced a new Web site - www.pistachiorecall.org - that lists specific pistachio products and brands that do not contain pistachios from Setton Pistachio of Terra Bella, Inc.

The Web site is produced by CAL-PURE, a co-op of California pistachio growers ("CAL-PURE"), and the Western Pistachio Association ("WPA") and is accessible directly and via a link on the FDA Web site at www.fda.gov/pistachios. The new site is being made available in light of a pistachio recall by the processor, Setton Pistachio of Terra Bella, Inc., due to potential Salmonella contamination. The recall action has been taken on a precautionary basis, and the FDA reports no illnesses tied to the recalled pistachios.

Only pistachios processed by Setton Pistachio of Terra Bella, Inc. are affected by the recall measures, and the majority of processors, pistachio products and foods containing pistachio products do not contain pistachios from Setton. The new Web site, www.pistachiorecall.org, will be updated on an ongoing basis to ensure consumers have access to the latest, most accurate information available related to such products.

The health and safety of consumers is the pistachio growers and processors number-one priority and, as such, CAL-PURE and the WPA are committed to continuing to work closely with regulators and industry leaders to address questions about pistachio safety. The pistachio community is dedicated to providing a safe, wholesome product and is eager to quickly put any concerns to rest so that consumers can enjoy pistachios and pistachio products with c
'/>"/>

SOURCE Western Pistachio Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Paramount Farms Establishes Scientific Advisory Board to Advance Understanding of the Health Benefits of Pistachios
2. Eating Pistachios Helps Reduce Cardiovascular Risk
3. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
4. Latest Pistachio Study Reveals Significant Reduction in Markers of Inflammation - an Emerging Risk Factor in Heart Disease
5. Kroger Recalls Shelled Pistachios Due to Possible Health Risk
6. FDA Investigating Salmonella-Tainted Pistachios
7. Trust for Americas Health on the Recall of Certain Pistachios and the U.S. Food Safety System
8. Raw Nuts Could Be Salmonella Source in Pistachios: Report
9. Pistachio Growers and Processors Announce New Web Site to Inform Consumers, Retailers of Safe Pistachio Brands
10. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
11. Western Growers Asks for Congressional AG Committee Hearings Regarding Salmonella Outbreak and Investigations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10VAs Health System Top Employer for AARP 58061 1VAs Health System Top Employer for AARP 58061 2Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 1Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 2Journalists invited to Darwin Chicago 2009 conference Oct 29 31 10039 1